Portolan Capital Management, LLC

Position in FLGT — Fulgent Genetics, Inc.

CIK 1350290 BOSTON, MA

Position in FLGT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,695,607

-$2,759,522 QoQ

Shares Held

106,642

-37.1% QoQ

Ownership

0.388%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Portolan Capital Management, LLC holds $45,511,852 across 5 Diagnostics & Research names.

#	Ticker	Company	Shares	Value (USD)
1	CDNA	CareDx, Inc.	684,805	$19,516,942
2	WGS	GeneDx Holdings Corp.	200,315	$13,751,624
3	CSTL	Castle Biosciences Inc	328,818	$7,842,309
4	NTRA	Natera, Inc.	8,532	$2,316,011
5	GH	Guardant Health, Inc.	13,897	$2,084,966

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,695,607	106,642	-37.1%	Shares	Sole	2026-05-15
2025-12-31	$4,455,129	169,590	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.